XORTX Therapeutics Inc. (XRTX) — This stock currently has no analyst coverage. No price targets, ratings, or earnings estimates are available. This is common for preferred shares, warrants, OTC-traded securities, and smaller companies that are not followed by Wall Street analysts.
分析师预估 每股收益(EPS)为 $-1.50 和 营收为 $0.00B (下一财年).
每股收益(EPS)历史表现: 2024: 实际 $-7.90 vs 预期 $-1.50 (不及预期 -426.7%). 2025: 实际 $-3.90 vs 预期 $-0.69 (不及预期 -465.1%). 分析师准确度: 18%.
